Articular Joint Implant by Boyan, Barbara D. et al.
c12) United States Patent 
Boyan et al. 
(54) ARTICULAR JOINT IMPLANT 
(75) Inventors: Barbara D. Boyan, Atlanta, GA (US); 
Stephen J. Kennedy, Alpharetta, GA 
(US); Zvi Schwartz, Atlanta, GA (US) 
(73) Assignee: Georgia Tech Research Corporation, 
Atlanta, GA (US) 
( *) Notice: Subject to any disclaimer, the term ofthis 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 0 days. 
This patent is subject to a terminal dis-
claimer. 
(21) Appl. No.: 13/427,648 
(22) Filed: Mar. 22, 2012 
(65) Prior Publication Data 
US 2012/0185051 Al Jul. 19, 2012 
Related U.S. Application Data 
(63) Continuation of application No. 12/117,673, filed on 
May 8, 2008, now Pat. No. 8,142,808, which is a 
continuation of application No. 11/053,410, filed on 
Feb. 7, 2005, now Pat. No. 8,002,830. 
(60) Provisional application No. 60/542,514, filed on Feb. 
6, 2004. 
(51) Int. Cl. 
A61F 2130 (2006.01) 
(52) U.S. Cl. 
USPC ..... 424/423; 623/18.11; 623/23.5; 623/23.76 
( 58) Field of Classification Search 
None 
See application file for complete search history. 
(56) References Cited 
U.S. PATENT DOCUMENTS 
3,276,996 A 10/1966 Lazare 
3,663,470 A 5/1972 Nishimura et al. 
3,673,612 A 7/1972 Merrill et al. 
3,849,238 A 1111974 Gould et al. 
3,859,421 A 111975 Hucke 
4,083,906 A 4/1978 Schindler et al. 
4,205,400 A 6/1980 Shen et al. 
4,351,069 A 9/1982 Ballintyn et al. 
4,472,542 A 9/1984 Nambu 
4,517,295 A 5/1985 Bracke et al. 
4,524,064 A 6/1985 Nambu 
4,609,337 A 9/1986 Wichterle et al. 
4,663,358 A 5/1987 Hyon et al. 
4,664,857 A 5/1987 Nambu 
4,693,939 A 9/1987 Ofstead 
4,731,081 A 3/1988 Tiffany et al. 
4,734,097 A 3/1988 Tanabe et al. 
4,738,255 A 4/1988 Goble et al. 
4,753,761 A 6/1988 Suzuki 
4,759,766 A 7/1988 Buettner-Janz et al. 
4,772,284 A 9/1988 Jefferies et al. 
4,784,990 A 1111988 Nimrod et al. 
4,787,905 A 1111988 Loi 
4,808,353 A 2/1989 Nambu et al. 
4,828,493 A 5/1989 Nambu et al. 
I lllll llllllll Ill lllll lllll lllll lllll lllll 111111111111111111111111111111111 
DE 
EP 
US008486436B2 
(IO) Patent No.: 
(45) Date of Patent: 
4,851,168 A 7/1989 
4,911,720 A 3/1990 
4,916,170 A 4/1990 
4,988,761 A 111991 
4,995,882 A 2/1991 
5,047,055 A 9/1991 
5,080,674 A 111992 
5,095,037 A 3/1992 
5,106,743 A 4/1992 
5,106,876 A 4/1992 
5,108,428 A 4/1992 
5,108,436 A 4/1992 
5,118,667 A 6/1992 
5,141,973 A 8/1992 
5,171,322 A 12/1992 
5,171,574 A 12/1992 
5,192,326 A 3/1993 
5,206,023 A 4/1993 
5,219,360 A 6/1993 
5,234,456 A 8/1993 
5,244,799 A 9/1993 
5,258,023 A 1111993 
5,258,042 A 1111993 
5,258,043 A 1111993 
5,260,066 A 1111993 
5,287,857 A 2/1994 
5,288,503 A 2/1994 
US 8,486,436 B2 
*Jul. 16, 2013 
Graiver et al. 
Collier 
Nambu 
Ikada et al. 
Destouet et al. 
Bao et al. 
Jacobs et al. 
Iwami tsu et al. 
Franzblau et al. 
Kawamura 
Capecchi et al. 
Chu et al. 
Adams et al. 
Kobayashi et al. 
Kenny 
Kuberasampath et al. 
Bao et al. 
Hunziker 
Georgiade 
Silvestrini 
Anderson 
Reger 
Mehta 
Stone 
Wood et al. 
Mann 
Wood et al. 
(Continued) 
FOREIGN PATENT DOCUMENTS 
20218703 Ul 3/2003 
0222404 Al 5/1987 
(Continued) 
OTHER PUBLICATIONS 
Andrade et al., "Water as a Biomaterial," Trans. Am. Soc. Artif. 
Intern. Organs, 19:1 (1973). 
Ariga et al., "Immobilization of Microorganisms with PVA Hardened 
by Iterative Freezing and Thawing," Journal of Fermentation Tech-
nology, 65(6): pp. 651-658 (1987). 
Boyan et al., "Effect of Titanium Surface Characteristics on 
Chondrocytes and Osteoblasts in Vitro," Cells and Materials, vol. 5, 
No. 4, pp. 323-335 (1995). 
Boyan et al., "Osteoblast-Mediated Mineral Deposition in Culture is 
Dependent on Surface Microtopography," Calcif. Tissue Int., 71 :519-
529 (2002). 
Bray et al., Poly(vinyl alcohol) Hydrogels for Synthetic Articular 
Cartilage Material, M. Biomed. Mater. Res., vol. 7, pp. 431-443, 
1973. 
Brunette, "The Effects oflmplant Surface Topography on the Behav-
ior of Cells," Int. J. Oral Maxillofac Implants, 3:231-240 (1988). 
(Continued) 
Primary Examiner - Savitha Rao 
Assistant Examiner - Gregg Polansky 
(74) Attorney, Agent, or Firm - Knobbe, Martens, Olson & 
Bear, LLP 
(57) ABSTRACT 
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ARTICULAR JOINT IMPLANT 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation of U.S. patent applica-
tion Ser. No. 12/117,673, filed May 8, 2008, which is a con-
tinuation ofU.S. patent application Ser. No. 11/053,410, filed 
Feb. 7, 2005 and issued on Aug. 23, 2011 as U.S. Pat. No. 
8,002,830, which claims the benefit of U.S. Provisional 
Patent Application Ser. No. 60/542,514, filed Feb. 6, 2004, the 
entireties of all of which are incorporated by reference herein. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to the use of surface modified 
biocompatible materials to promote the attachment ofbone or 
bone-like cells to an implant surface. The surface of the 
biomaterials, which may include hydrogels, when modified 
in accordance with the description herein, directs the cells 
that migrate to the implant site to differentiate into cells that 
attach and lay down bone or bone-derivative material, or 
cartilage or cartilaginous material further enhancing the bio-
compatibility of the implanted device. 
2. Background Art 
Materials used in the construction of implantable medical 
devices must be nontoxic, nonantigenic, and noninflamma-
tory. Hydrogels are a preferred type of polymeric material for 
implantable devices. Because of their high water content, 
analogous to living tissue, they are superior in biocompatibil-
ity to non-hydrous polymeric materials. 
U.S. Pat. No. 5,981,826, issued to Ku et al., describes the 
preparation of polyvinyl alcohol hydrogels (PVA-H) by 
physically crosslinking an aqueous solution of polyvinyl 
alcohol (PVA) to produce a gel. The crosslinking is accom-
plished by subjecting the aqueous PVA solution to multiple 
cycles of freezing and thawing. One limitation of the prior art 
2 
merization ofhydrogels are derived from methods used in the 
polymer industry and are well known in the art. 
Artificial discs intended for the replacement of a damaged 
intravertebral disc have been described. These are typically 
articulated devices comprising two rigid metal plates adhered 
to opposite ends of an elastomeric core. In use, the artificial 
disc is placed in the intervertebral space and the metal plates 
are secured to the surfaces of adjacent vertebrae. Various 
embodiments of artificial discs of this type are described in 
10 
U.S. Pat. Nos. 5,674,296 and 6,156,067, issued to Bryan et 
al., U.S. Pat. No. 5,824,094, issued to Serhan et al., U.S. Pat. 
No. 6,402,785, issued to Zdeblick et al. More recent embodi-
ments, e.g. U.S. Pat. No. 6,419,704, issued to Ferree and U.S. 
Pat. No. 6,482,234, issued to Weber et al., include descrip-
tions of elastomeric cores that may be formed from materials 
15 with different elasticities to better mimic the native structure 
of spinal discs. 
The disadvantages of the artificial disc devices of the prior 
art are numerous. These prior art devices require the mechani-
cal attachment of rigid artificial materials, such as titanium, 
20 directly to the bone with screws, staples, nails, cement, or 
other mechanical means. These rigid materials are only mini-
mally compatible with natural, living bone and separation of 
the implant from the bone is often observed over long-term 
implantation. In addition, materials used in artificial discs of 
25 the prior art have physical and mechanical properties dis-
tinctly different from those of natural spinal, discs and thus, 
inadequately duplicate the desired properties of native spinal 
discs. 
Vertebral fusion is still the most commonly performed 
procedure to treat debilitating pain associated with degenera-
30 tive spinal disc disease or disc trauma, despite the fact that the 
procedure has many drawbacks. Vertebral fusion increases 
stress and strain on the discs adjacent to the fusion site, and it 
is now widely accepted that fusion is responsible for the 
accelerated degeneration of adjacent levels. Current multi-
35 component spinal disc prosthesis designs, elastomeric cores 
with metal plates on both the upper and lower surfaces, are 
susceptible to problems with interfacial bonding and wear. 
These designs have shown spontaneous device detachment 
is that the hydrogels produced are relatively nonporous and 
the pore size and degree of porosity, that is the density of the 40 
pores within the hydrogel, cannot vary independently of the 
mechanical properties or stiffness of the hydrogel. 
due to retraction of bone tissue from the metal surface. 
Bone ingrowth and attachment in the art has often required 
the use of bone promoting growth factors. For example, U.S. 
Pat. No. 5,108,436, issued to Chu et al., describes using a 
porous implant for use in load bearing bone replacement 
which is used in combination with an osteogenic factor such 
Methods for producing certain porous hydrogels also exist 
in the art. U.S. Pat. No. 6,268,405 issued to Yao et al., 
describes methods for creating porous PVA-Hs by including 
immiscible materials in the polymerization process. After the 
hydrogel is polymerized, the included immiscible materials 
are washed out of the hydrogel by an appropriate solvent, 
yielding pores which are broadly distributed throughout the 
hydrogel. Controlling the size and density of the pores is 
accomplished by varying the molecular weight of the immis-
cible materials. A disadvantage ofYao et al. is that the range 
of attainable pore sizes is limited. Moreover, the invention of 
Yao et al. is limited in that it can only produce hydrogels 
whose pores extend throughout the hydrogel. The pores in 
Yao et al. are intended to create vascularization of the hydro-
gel in soft or non-load bearing tissue. A further disadvantage 
ofYao et al. is that the pore sizes are broadly distributed about 
the average pore size. 
45 as TGF-~. 
Biomedical devices which are implanted in or around bone 
often fail because of fibrinogen encapsulation of the implant 
instead of cellular attachment to the implant itself. This 
encapsulation is a defensive reaction attempting to minimize 
50 contact between the body and the implant and is considered a 
sign of implant incompatibility. 
Moreover, the art of bone ingrowth to implantable surface 
contains a multitude of examples relating to porous directed 
ingrowth where bone essentially grows into and around chan-
55 nels of the implant. For example, U.S. Pat. No. 4,911,720, 
issued to Collier et al., discusses the ingrowth of bone into 
interconnecting pores which essentially locks bone into 
place. This method is disadvantageous in that bone does not 
actually attach to the material, instead bone attaches to other 
60 bone around the implant. In the unfortunate event that an 
implant must be removed, this type of Collier ingrowth results 
in large amounts of disruption to the surrounding bone tissue. 
In addition to crosslinking by physical means, hydrogels 
may be chemically crosslinked using, for example, methods 
similar to those described by Muller in U.S. Pat. No. 5,789, 
464. Similarly, chemical crosslinking or polymerization 
methods may also be used to adhere hydrogels to surfaces, 
including biological tissues. U.S. Pat. No. 5,900,245, issued 65 
to Sawhney et al., describes applications of these techniques. 
These and other methods for the crosslinking or further poly-
SUMMARY OF THE INVENTION 
The present invention describes a biomaterial for implan-
tation into the body. The biomaterial, which can be a hydro-
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gel, possesses a textured surface which is comprised of super-
ficial surface pores. Stated differently, the pores on the 
surface of the hydro gel substrate do not extend throughout the 
hydrogel but instead remain within a region near the surface. 
The hydrogel substrate can be comprised of two or more pore 
sizes. Specifically, the pores of the first size each have a 
diameter of between 3 and 1000 micrometers, preferably 
between 10 and 300 micrometers, and preferably between 30 
and 100 micrometers. Further, the pores of the second size 
would each have a diameter of between 0.5 to 20 microme- 10 
ters, preferably between 1 to 10 micrometers, and preferably 
between 2 and 5 micrometers. One embodiment of the present 
invention provides the second, smaller pores disposed within 
the first, larger pores. The superficial pores of the present 
invention extend into the hydrogel substrate less than 1 mil- 15 
limeter, preferably 500 micrometers, and preferably 200 
micrometers, from the surface. The hydrogel substrate of the 
present embodiment can comprise polyvinyl alcohol having a 
water content of at least 5% and preferably at least 30%. 
The present invention is also drawn to a hydrogel substrate 20 
comprising a hydrogel surface having thereon a plurality of 
first substantially uniform superficial pores and a unique plu-
rality of second substantially uniform superficial pores. This 
hydrogel can possess two different yet substantially uniform 
superficial pore sizes grouped into a first, larger pore size and 25 
a second, smaller pore size. The pores of one size are sub-
stantially uniform in diameter relative to the other pores of the 
same size. Specifically, the first pores have an average diam-
eter of between 2 and 600 micrometers, preferably between 5 
and 200 micrometers, and preferably between 20 and 60 30 
micrometers. Further, the second pores have an average diam-
eter of between 0.1and10 micrometers, preferably between 
0.2 to 5 micrometers, and preferably between 0.5 to 2 
micrometers. The superficial pores of the present invention 
can be arranged so that the smaller, second pores are within 35 
the larger, first pores. The superficial pores of the present 
invention extend into the hydrogel substrate less than 1 mil-
limeter, preferably no more than 500 micrometers, and pref-
erably no more than 200 micrometers. The hydrogel substrate 
of the present embodiment can be made up of polyvinyl 40 
alcohol having a water content of at least 5% and preferably 
at least 30% w/w of the overall hydrogel. 
BRIEF DESCRIPTION OF DRAWINGS 
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have a diameter of between 3 and 1000 micrometers, prefer-
ably between 10 and 300 micrometers, and preferably 
between 30 and 100 micrometers, including without limita-
tion, pores with a cross-section of30, 40, 50, 60, 70, 80, 90, 
and 100 micrometers. Further, the pores of the second size 
preferably each have a diameter of between 0.5 to 20 
micrometers, preferably between 1 to 10 micrometers, and 
preferably between 2 and 5 micrometers, including without 
limitation, pores with a cross-section of0.5, 1, 2, 3, 4, 5, 6, 7, 
8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and20 micrometers. 
It should be readily apparent to one of ordinary skill in the art 
that the use of the term diameter also would encompass the 
cross-section of the pore when not a perfect circle. In fact, the 
term "pore" should not be read to be limited to circular or 
spherical shapes. Squares, polygons, triangles, octagons, 
quadrahedrens, or any other geometric or amorphic structure 
would perform the function for the invention if properly posi-
tioned and sized. One embodiment of the present invention 
provides the second, smaller pores within the first, larger 
pores. The invention provides that third, fourth, fifth, and 
greater substantially uniform pore sizes can be on the hydro-
gel surface. By substantially uniform it is meant that the pore 
sizes of a particular class (e.g., first, second, etc.) do not vary 
more than 10%, preferably the pore sizes of a particular class 
vary less than 5%, 4%, 3%, more preferably less than 2%, and 
preferably less than 1 % or 0.5%. 
The superficial pores of the present invention would extend 
into the hydrogel substrate no more than 1 millimeter, pref-
erably 500 micrometers, and preferably 200 micrometers, 
from the surface. The hydrogel substrate of the present 
embodiment can comprise polyvinyl alcohol having a water 
content of at least 5% and preferably at least 30% w/w of the 
overall hydrogel. 
The present invention is also drawn to a hydro gel substrate 
comprising a hydrogel surface having thereon a plurality of 
first substantially uniform superficial pores and a unique plu-
rality of second substantially uniform superficial pores. This 
hydro gel substrate can possess two different yet substantially 
uniform superficial pore sizes grouped into a first, larger pore 
size and a second, smaller pore size. The pores of one size are 
substantially uniform in diameter relative to the other pores of 
the same size. Specifically, the first pores have an average 
diameter of between 2 and 600 micrometers, preferably 
between 5 and 200 micrometers, and preferably between 20 
FIG. 1 is a spinal disc replacement device made in accor-
dance with one embodiment of the present invention. 
FIG. 2 is an example of a superficial surface pore construct 
exemplary of one embodiment of the present invention. 
45 and 60 micrometers. Further, the second pores have an aver-
age diameter of between 0.1and10 micrometers, preferably 
between 0.2 to 5 micrometers, and preferably between 0.5 to 
2 micrometers. 
FIG. 3 are multiple types of superficial surface pores 
embodied by the present invention. 
FIG. 4 is a graph of cell proliferation seen on the surfaces 
of FIG. 3. 
FIG. 5 is a graph of increased bone or bone-like cell mark-
ers resulting from exposure to the surfaces of FIG. 3. 
FIG. 6 is an image of a substrate which has been generated 
in accordance with the present invention. The upper image is 
a further magnification of the image in the lower portion of 
FIG. 6. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention is drawn to a biomaterial substrate 
which may comprise a hydrogel surface having thereon a 
plurality of first substantially uniform superficial pores and a 
unique plurality of second substantially uniform superficial 
pores. Specifically, the pores of the first size preferably each 
The superficial pores of the present invention can be 
50 arranged so that the smaller, second pores are within the 
larger, first pores. The superficial pores of the present inven-
tion can extend into the hydro gel substrate preferably no more 
than 1 millimeter, preferably no more than 500 micrometers, 
and preferably no more than 200 micrometers. The hydrogel 
55 substrate of the present embodiment can be made up of poly-
vinyl alcohol having a water content of at least 5% and pref-
erably at least 30% w/w of the overall hydrogel. 
In one embodiment of the invention, the superficial pores 
of the substrate described herein can be arranged in a regular 
60 repeating fashion. Such a patter or waffle structure can be 
used in embodiments of varying pore size as well as in 
embodiments where the smaller superficial pores are within 
the area of the larger superficial pores. 
A method provided by the present invention of making a 
65 hydrogel substrate possessing a textured surface required by 
the present invention comprises using an extremely accurate 
etching technology to generate a mold, pouring a liquid solu-
US 8,486,436 B2 
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ti on of the hydro gel into the mold, allowing the liquid hydro-
gel to polymerize and/or crosslink while in the mold, and 
removing the solid hydrogel substrate from the mold. The 
extremely accurate etching technology can be MEMS tech-
nology or its equivalent. Also, the hydrogel substrate made 
from this method could be a polyvinyl alcohol hydrogel hav-
ing a water content of at least 5% and preferably at least 30% 
w/w of the overall hydrogel. 
6 
sulfonic acid, allylsulfonic acid, vinyltoluenesulfonic acid 
and vinylbenzenephosphonic acid. 
From the example listing above, a hydrogel for use in the 
present invention may be selected based upon its biocompat-
ibility and stability at various hydration states. For the pur-
poses of the present invention, a suitable hydro gel will have a 
moisture content of at least 5% w/w of the overall hydrogel, 
preferably at least 10%, 15%, 20%, 25%, 30%, 35%, 40%, 
50%, 60%, 70%, or 80% w/w of the overall hydrogel. 
Initial events following implantation of a biomaterial in an 
orthotopic surgical site include rapid adsorption of serum 
constituents onto the implant surface. The first cells that are 
likely to come into contact with the surface are polymorpho-
nuclear cells, platelets, monocytes, and macrophages. These 
The present invention also includes a method for making a 
hydrogel substrate by contacting solid objects with a liquid 10 
hydrogel, allowing the hydrogel to polymerize and crosslink 
while the solid objects are at least partially immersed in the 
hydrogel, and removing those solid objects from the polymer-
ized and crosslinked hydrogel to form superficial pores 
therein. The solid objects used to impart the superficial pores 
may be made of polystyrene beads. Also, the solid objects 
used to impart the superficial pores may be grit, sand, silicon, 
silica, and ultra-fine particulate matter. The solid objects used 
15 cells release bioactive factors that promote mesenchymal cell 
migration to the wound site. In addition to these natural 
factors associated with wound healing, surgeons frequently 
use bone graft and bone graft substitutes to improve bone 
formation. Such materials include osteoinductive agents such 
to create the superficial pores can have a diameter of between 
3 and 1000 micrometers, preferably between 10 and 300 
micrometers, and preferably between 30 and 100 microme-
ters. 
The solid objects used to create the superficial pores ofthis 
invention can be removed by use of an organic solvent or 
other washing means. This hydrogel can be comprised of 
polyvinyl alcohol possessing a water content of at least 5% 
w/w of the overall hydrogel. 
20 as demineralized bone matrix and bone morphogenetic pro-
tein. If appropriate signals are present mesenchymal cells 
with an osteoprogenitor phenotype will continue to differen-
tiate into osteoblasts; of these a subset will become osteo-
cytes. Ultimately, the newly formed bone will be remodeled 
25 via osteoclastic resorption. The invention provides that physi-
cal stimulation of cells via a controllably textured surface 
contributes to desired cellular differentiation, adhesion, and 
acceptance of the implant. The present invention also pro-
vides that well-known grafting agents may be incorporated Accordingly, the present invention is directed to an 
implantable hydrogel substrate product, a method of making 
that product, and a method of using that product which sub-
stantially improves upon the limitations existing in the art. 
The invention provides methods of selectively promoting 
cellular residence and/or differentiation over a surface as 
described herein. To achieve these and other advantages in 35 
accordance with the purpose of the invention, as embodied 
and broadly described herein, the invention includes a load 
bearing biocompatible hydrogel for medical implantation 
that promotes bone attachment. The hydrogel consists of a 
surface component which has been optimized for implanta- 40 
tion. This is accomplished through pores on the surface hav-
ing a controlled range in distribution of size. The surface 
pores are superficial and do not extend throughout the hydro-
gel. 
30 into the hydrogel composition, which include, but are not 
limited to growth factors, angiogenic agents, antibiotics, and 
the like. 
Hydrogels are materials whose state is between that of a 45 
solid and of a liquid. Gels consist of polymeric, i.e. long 
chain, molecules linked together to form a three-dimensional 
network and are embedded in a liquid medium. In the case of 
hydrogels, the liquid medium comprises water. The polymer 
backbone of hydrogels is formed by hydrophilic monomer 50 
units and may be neutral or ionic. Examples of neutral and 
hydrophilic monomer units are ethylene oxide, vinyl alcohol, 
(meth)acrylamide, N-alkylated (meth)acrylamides, N-me-
thylol(meth)acrylamide, N-vinylamides, N-vinylformamide, 
N-vinylacetamide, N-vinyl-N-methylacetamide, N-vinyl-N- 55 
methylformamide, hydroxyalkyl (meth)acrylates such as 
hydroxyethylmethacrylate, vinylpyrrolidone, (meth)acrylic 
esters of polyethylene glycol monoallyl ethers, ally! ethers, of 
polyethylene glycols, and sugar units such as glucose or 
galactose. Examples of cationic hydrophilic monomer units 60 
are ethyleneimine (in the protonated form), diallyldimethy-
lammonium chloride and trimethylammonium propyl-
methacrylamide chloride. Examples of anionic monomer 
units are (meth)acrylic acid, crotonic acid, maleic acid, 
fumaric acid, itaconic acid, 2-acrylamido-2-methylpropane- 65 
sulfonic acid, vinylsulfonic acid, vinylphosphonic acid, 
2-methacryloyloxyethanesulfonic acid, 4-vinylbenzene-
Chemically modified or polar surfaces are generally 
known to be able to produce more reactive protein adsorption 
to the implant surface than unmodified or non-polar surfaces. 
The increased reactivity of the proteins adsorbed onto the 
polar surface is thought to promote cellular adhesion to that 
surface. Therefore, the invention provides that the hydrogel 
composition can possess chemically modified or polar sur-
faces. 
In general, many materials are well-tolerated in bone, but 
the success of long-term or chronic implantation often 
depends on the intimacy of the interface between the material 
surface and the bone. Microarchitecture of the surface is an 
important determinant of cell response. It has been observed 
that osteoblast phenotypic expression is surface-dependent. 
As described herein, specific surface characteristics enhance 
osteoblast differentiation while permitting proliferation, 
leading to optimal cell response to the implantation. Like-
wise, cartilage or cartilage-derivative cells show enhanced 
differentiation based on surface microarchitecture. Since 
both bone and cartilage cells are derived from mesenchymal 
stem cells and have as a common ancestor, osteoprogenitor 
cells, the present invention refers to bone and bone-like cells 
to encompass that branch of the differentiation pathway. 
Stated differently, the present invention provides for the dif-
ferentiation of bone cells (for example osteocytes, osteo-
blasts, osteoclasts) as well as bone-like cells (for example 
chondrocytes or related cartilaginous tissue producing cells). 
The mechanical properties of the material must be appro-
priate for the application. When the mechanical properties of 
the material are similar to the mechanical properties of the 
tissue adjacent to the implant, tissue tolerance of the artificial 
material is enhanced. Polymeric and elastomeric biomaterials 
can be fabricated with a wide range of mechanical properties, 
making them suitable for many applications as implantable 
devices. Because of their high water content, similar to that of 
US 8,486,436 B2 
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living tissue, hydrogels are superior in biocompatibility to 
non-hydrous polymeric materials. Polyvinyl alcohol (PVA) is 
an example of a polymer that can be used to form hydro gels, 
and has been studied extensively for its potential in biomedi-
cal applications. Polyvinyl alcohol hydrogels (PVA-Hs) are 
biologically well tolerated and compatible with living carti-
lage tissue. 
PVA-Hs can be produced from solution via repeated freez-
ing and thawing cycles that increase the order of the microc-
rystalline regions, changing the dissolution properties, mesh 10 
size, and diffusion properties of the polymer. Also, PVA-Hs 
can be produced from solution via a slow and sustained tran-
sition through the freezing point of the solution. The 
mechanical properties of PVA-Hs can be varied over a wide 
range, and stable PVA gels can easily be produced to have an 15 
elastic modulus ranging from a few MPa, such as articular 
cartilage, to about 50 MPa, such as the stiffest portion of the 
annulus of spinal discs. Increasing the stiffness of a hydro gel 
can also be achieved through chemical crosslinking. 
Examples of chemical crosslinker groups are vinyl groups, 20 
ally! groups, cinnamates, acrylates, diacrylates, oligoacry-
lates, methacrylates, dimethacrylates, oligomethacrylates, or 
other biologically acceptable groups. 
Increasing the porosity of a hydrogel substrate produces 
decreased mechanical strength. When porous hydrogels are 25 
used to provide the requisite surface of the present invention, 
it is advantageous that the porosity not extend throughout the 
hydrogel, but be limited to a relatively shallow depth below 
the surface. The thickness of the porous portion of the hydro-
gel is preferably less than 1 millimeter, less than 500 30 
micrometers, and most preferable less than or equal to 200 
micrometers. 
8 
Photo lithography is the process of transferring geometric 
shapes on a mask to the surface of a silicon wafer. The steps 
involved in the photolithographic process are wafer cleaning; 
barrier layer formation; photoresist application; soft baking; 
mask alignment; exposure and development; and hard-bak-
ing. 
There are two types of photoresist: positive and negative. 
For positive resists, the resist is exposed with UV light wher-
ever the underlying material is to be removed. In these resists, 
exposure to the UV light changes the chemical structure of the 
resist so that it becomes more soluble in the developer. The 
exposed resist is then washed away by the developer solution, 
leaving windows of the bare underlying material. The mask, 
therefore, contains an exact copy of the pattern which is to 
remain on the wafer. 
Negative resists behave in just the opposite manner. Expo-
sure to the UV light causes the negative resist to become 
polymerized, and more difficult to dissolve. Therefore, the 
negative resist remains on the surface wherever it is exposed, 
and the developer solution removes only the unexposed por-
tions. Masks used for negative photoresists, therefore, con-
tain the inverse (or photographic "negative") of the pattern to 
be transferred. 
MEMS fabrication of hydrogel mold surfaces for use in 
this invention may, for example, involve standard photoli-
thography techniques and epoxy-based photoresists (SU-8 
2000 series, MicroChem, Newton, Mass.) in a Class 10 clean-
room facility. Photolithography masks can be designed, for 
example, using a CAD program, or its equivalent, and sup-
plied to order (DuPont Photomasks, Inc., Round Rock, Tex.). 
One embodiment of this invention is an artificial interver-
tebral disc, comprising one or more hydrogels shaped sub-
stantially similarly to a natural intervertebral disc. The upper 
and lower surfaces of the hydro gel, or assembly ofhydrogels, 
The porosity of the hydrogel surface embodied in this 
invention may be realized in a variety of ways. Molds may be 
constructed with patterning on the appropriate surfaces of the 
cavities in the mold. Alternatively, the porosity can be pro-
duced by abrasion of a smooth hydrogel surface after mold-
ing. Abrading the surface can result in a surface textured such 
35 are constructed to have a textured surface with a defined level 
of porosity. That porosity depends primarily upon the size and 
number of the surface features of the mold used to create the 
surface texture. 
as desired in this invention. Techniques for applying and 
using abrasives are well known to those of skill in the art. 
Using extremely accurate surface building or etching tech-
niques, one can generate extremely intricate surfaces to use as 
Another embodiment of this invention is a substrate used to 
40 repair tissue that has been damaged either chronically or 
acutely. This substrate can be implanted at a damaged area 
such as knee cartilage, shoulder bursa repair, or other dam-
aged area one skilled in the art would foresee. a mold for a surface envisioned by the present invention. Solid 
free-form fabrication methods offer several unique opportu-
nities forthe construction of medical devices. Solid free-form 45 
FIG. 1 shows a spinal disc replacement envisioned by the 
present invention. The spinal disc has an upper portion 1 and 
a lower portion 2. It is the surfaces of the upper portion 1 and 
lower portion 2 which possess the textured surface envisioned 
by the present invention. The upper portion 1 and lower 
portion 2 will be less elastic and more rigid than the inner 
fabrication methods can be used to selectively control com-
position within the build plane by varying the composition of 
printed material. This means that unconventional micro struc-
tures, such as those with complicated porous networks or 
unusual gradients, can be designed at a computer-aided 
design (CAD) terminal and built through a solid free-form 
process such as three-dimensional printing or MEMS micro-
fabrication techniques. 
In one embodiment ofthis invention the molds for casting 
the hydrogels are created using MEMS micro-fabrication 
techniques to produce materials with precise repetitive 
arrays. The microfabrication process uses commercially 
available, epoxy-based photoresist and standard photolithog-
raphy masks and techniques to produce the specified surface 
architecture. The dimensions of features in the x-y plane of 
the surface are specified by the photomask. The height of the 
features is dictated by the thickness of the photoresist layer 
prior to exposure and development. Multiple photoresist lay-
ers may be cast and exposed with different masks to build up 
very complex structures. An example of one such complex 
feature, with a pseudofractal architecture is shown in the 
"snowflake" pattern, seen in FIG. 2. 
50 region 4 which seeks to mimic the nucleus pulposus. Like-
wise, the spinal disc may have an intermediate region of 
elasticity 3 which further aids in the function of the spinal 
disc. The intermediate region of elasticity 3 may or may not 
differ from the elasticity of either the inner region 4 or the 
55 upper portion 1 or lower portion 2. 
The size of the pores comprising the textured surface of the 
hydro gel can aid in promoting adhesion of one cell type over 
the other. For example, bone cells can show better attachment 
and results on textured surfaces where the pores are larger 
60 than the pores on a textured surface where cartilage cells 
attach. The ability to promote bone cells to attach to a given 
surface as compared to cartilage cells can be considered in the 
design of an implant. For example, a biomedical implanted 
device which needs a more rigid attachment to the native bone 
65 might require the attachment of bone cells as opposed to 
cartilage cells, requiring using a surface with larger pores. 
Likewise, a different implant may need to induce cartilage 
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development on the surface of the implant and would instead 
use the textured surface composed of overall smaller pores to 
enable that selection. Other factors such as the age, sex, and 
pre-existing medical condition of the patient would be con-
sidered depending upon the circumstances. 
Conversely, the present invention provides for a hydrogel 
substrate that can be implanted which possesses multiple 
regions on that substrate capable of promoting the differen-
tiation and attachment of both bone and bone-like cells such 
as, for example, osteocytes and chondrocytes. Such a surface 
would, after the migration of mesenchymal stem cells, pro-
mote the differentiation of the mesenchymal stem cell into the 
osteoprogenitor cell and ultimately into bone and cartilage 
cells on each type's respective region. Stated differently, the 
present invention provides for a single hydro gel substrate that 
has both bone cell promoting regions and cartilage, or bone-
like cell, promoting regions. 
10 
FIG. 2 depicts a superficial pore 20 as envisioned by the 
present invention. The superficial pore contains a large pore 
10 and a small pore 15. The small pores 15 are located within 
the large pore 10. The small pores 15, in this embodiment, are 
equally spaced from one another by one diameter and are 
positioned in a hexagonal layout. 
The pores on the textured surface in this embodiment 
enable the surface to resemble native bone which has under-
gone osteoclastic resorption. Increasing the porosity of a 
10 PVA-H generally reduces the mechanical strength of the 
implant. When surface textured hydro gels are used to provide 
the requisite surface texture, it is advantageous for the pores 
not to extend throughout the hydrogel, but instead be limited 
15 to a relatively shallow depth below the textured surface. The 
thickness of the porous portion of the hydrogel is less than 1 
millimeter, preferably less than 500 micrometers, and prefer-
ably less than or equal to about 200 micrometers. 
In order to measure differentiation of cells into bone or 
20 bone-like cells four markers are known in the art. The pres-
ence of alkaline-phosphatase, TGF-~1, PGE2 , and osteocal-
cin function as reliable indicators of cellular differentiation 
into bone or bone-like cells. Specifically, it has been shown 
Osteoblasts assume distinct morphologies depending on 
the architectural features of their substrate. On microrough 
surfaces, as long as the peak-to-peak distance is less than the 
length of the cell body, the cell bodies become more cuboidal, 
and anchor themselves to the surface through long dendritic 
filopodia. In contrast, on smoother surfaces osteoblasts flatten 
and spread, resulting in a fibroblastic appearance. The cell 25 
morphology correlates with the physiological behavior of the 
cells. On smooth surfaces, prostaglandin synthesis is low, 
TGF-~ 1 levels are low, alkaline phosphatase specific activity 
that MG63 osteoblasts, NHOst cells, and fetal rat calvarial 
cells will attach to surfaces and then differentiate into secre-
tory osteoblasts that exhibit increased levels of alkaline phos-
phatase activity and osteocalcin. As surface microroughness 
increases, levels of PGE2 in the conditioned medium also 
increase. PGE2 stimulates osteoclastic activity at high levels, 
but is required to be present at low levels for osteoblastic 
activity to occur. It has been previously shown that the 
is low, and osteocalcin levels are low, whereas proliferation 
rates are relatively high in comparison with cells cultured on 30 
rougher surfaces. That is, a greater number of cells may be 
present on smooth surfaces, but the cells on textured surfaces 
show greater tendency to proliferate into bone or bone-like 
cells. 
elevated prostaglandin levels that are seen in cultures grown 
on rough microtopographies appear to be required for 
enhanced osteogenesis since inhibition of prostaglandin pro-
Responsiveness to the surface also depends upon the state 
of maturation of the cell in the osteoblast lineage. Examina-
tions of numerous cell lines and primary cell cultures from the 
multipotent fetal rat calvarial cells to the osteocyte cell line 
MLO-Y 4 have occurred. These experiments indicate that as 
cells become more mature, the stimulatory effect of the 
microrough surface on differentiation becomes attenuated. It 
is, however, only on textured surfaces and only in the pres-
ence of bone morphogenic protein-2 (BMP-2), that fetal rat 
calvarial cells are able to establish three dimensional nodules 
35 duction by indomethacin blocks the increase in osteoblast 
phenotypic expression on these substrates. 
TGF-~1 levels are also surface dependent. The amount of 
TGF-~1 produced by osteoblasts cultured on surfaces is 
modulated in a surface dependent marmer by factors that 
40 regulate osteogenesis and subsequent bone resorption. Regu-
lation ofTGF-~ 1 is important to bone formation for a number 
of reasons. This growth factor stimulates proliferation of 
mesenchymal cells and enhances the production of extracel-
lular matrix, particularly of type 1 collagen. 
Osteocalcin is the most abundant non-collagenous protein 
in bone, comprising almost 2% of total protein in the human 
body. It is important in bone metabolism and is used as a 
clinical marker for bone turnover, but its precise function 
remains elusive. With no known enzyme activity, osteocal-
that form mineral in a physiological relevant manner. The 45 
results support in vivo observations that a mineral can affect 
cells directly on the surface as well as distal to the biomaterial 
indicating that the extracellular signaling factors released by 
the cells in direct contact with material are sensed by other 
cells in the microenvironment, and potentially systematically 50 cin' s function depends on its structure. That structure reveals 
a negatively charged protein surface that places five calcium 
ions in positions complementary to those in hydroxyapatite, 
the structural mineral component of bone. In addition to 
binding to hydroxyapatite, osteocalcin functions in cell sig-
as well. 
The surface texture is created by the distribution of pores 
which do not continue throughout the hydrogel, or stated 
differently, are superficially located on the hydrogel sub-
strate. These pores can be broken into at least two size groups: 
large pores and small pores. The large pores can range in size 
from 3 to 1000 micrometers in diameter. Preferably, the large 
pores can range in size from 10 to 300 micrometers in diam-
eter. And preferably, the large pores can range in size from 30 
to 100 micrometers in diameter. The small pores are smaller 
in diameter. For example, the small pores can range in size 
from 0.5 to 20 micrometers in diameter. Preferably, the small 
pores can range in size from 1 to 10 micrometers. And pref-
erably, the small pores can range in size from 2 to 5 microme-
ters. The present invention also provides for third, fourth, 
fifth, and greater numbers of pore sizes on the hydro gel 
substrate. 
55 naling and the recruitment of osteoclasts and osteoblasts, 
which have active roles in bone resorption and deposition, 
respectively. 
The hydro gels of the present invention may contain bioac-
tive factors to further stimulate cell growth or differentiation. 
60 These factors, for instance attachment peptides, such as RGD 
containing peptides, and growth factors such as bone mor-
phogenic proteins, insulin-like growth factor, platelet derived 
growth factor, fibroblast growth factor, cartilage-derived 
growth factor, transforming growth factor-beta, and parathy-
65 raid hormone related peptide, as well as other regulatory 
chemicals such as statins, prostaglandins, and mineral ions 
are well known in the art. These factors may be included in the 
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hydrogels of this invention singly or in combination, and they 
may be included with or without their respective binding 
proteins. 
The hydro gels of the present invention may also contain 
bone or cartilage forming cells ( osteoblasts or chondrocytes) 
12 
dimethacrylates, oligomethacrylates, or other biologically 
acceptable photopolymerizable groups. 
In yet another embodiment of the present invention, the 
biocompatible material used in implantation is selected from 
the group of polymers, ceramics, metallics, organo-metallics, 
or other known biocompatible materials. To be used as 
described herein, the materials need to be castable, formed by 
the use of molds, in order to have rendered upon the surfaces 
of the materials the necessary forms embodied in this inven-
or precursor cells to bone and cartilage forming cells such as 
mesenchymal stem cells or osteoprogenitor cells. These pre-
cursor cells have the capacity to differentiate into bone and/or 
cartilage forming cells. Cells may be included in the hydro-
gels of the present invention alone or in combination with 
bioactive factors to further stimulate cell growth or differen-
tiation. 
10 tion. Castable ceramics would be a preferred selection as the 
materials are often formed in manners which resembled 
native bone or bone structures. Likewise, biocompatible 
metallic components could be fashioned using the various 
embodiments of this invention such to direct cellular attach-
Natural intervertebral discs have a tough outer fibrocarti-
laginous ring called the annulus fibrosus and a soft, inner, 
highly elastic structure called the nucleus pulposus. The arti-
ficial discs of the present invention may contain an inner core 
constructed to mimic the physical and mechanical properties 
15 ment and proliferation at the surface of the implant. 
of the natural nucleus pulposus, surrounded by an annular 
region constructed to mimic the physical and mechanical 
properties of the natural annulus fibrosus. 20 
In one embodiment, these regions comprise hydrogels 
whose water content, degree of polymerization, and degree of 
crosslinking are routinely adjusted to produce the requisite 
physical and mechanical properties. The hydrogel compris-
ing the inner core has a higher water content and/or a lower 25 
degree of polymerization and/or a lower degree of crosslink-
ing to produce a relatively soft and elastic hydrogel. The 
hydrogel comprising the outer annular region has a lower 
water content and/or a higher degree of polymerization and/or 
crosslinking to produce a relatively hard outer hydrogel 30 
which mechanically is tough and stiff. The hydrogels com-
prising the upper and lower surfaces may substantially 
resemble the hydro gel comprising the annular region in terms 
of physical and mechanical properties, water content, and 
degrees of crosslinking and polymerization. The additional 35 
requirement, however, for the surfaces to be textured may 
allow or require a different combination of physical and 
mechanical properties in these hydrogels compared to the 
hydrogel comprising the outer annular region. 
In yet another embodiment of the present invention, the 40 
hydrogel substrate can be a load bearing patch which can be 
used in the repair of partially or predominately damaged 
tissue. For example, the hydrogel substrate bearing the tex-
tured surface of the present invention can be relatively thin 
and small in diameter. That hydrogel substrate can then be 45 
placed where deteriorated, either acutely or chronically, car-
tilage was removed. 
In yet another embodiment of the present invention, the 
hydrogel substrate can be assembled outside the body in a 
malleable form. The malleable form of the hydro gel substrate 50 
can then be placed in the intended area, be it a spinal disc 
replacement, knee cartilage replacement, shoulder bursa 
repair, or other use one skilled in the art would foresee. Once 
in the proper position, the malleable hydro gel substrate could 
be hardened or polymerized via photopolymerization. Radia- 55 
ti on curing or photopolymerization (photo-induced free radi-
cal polymerization) has become an important and useful tech-
nique for applying and curing coatings, inks and adhesives. 
Radiation-curable compositions typically comprise as essen-
tial components one or more radiation-curable monomers and 60 
a photoinitiator. The compositions are applied as a coating to 
various articles and surfaces and the monomers are polymer-
ized to form a film by exposing the coating of the radiation-
curable composition to radiation, typically ultraviolet (UV) 
or electron-beam radiation. Examples of chemical 65 
crosslinker groups are vinyl groups, ally! groups, cinnamates, 
acrylates, diacrylates, oligoacrylates, methacrylates, 
EXAMPLES 
Example 1 
A simple mold surface pattern in accordance with this 
invention, for example, is an array of cylinders which are 5 µm 
in diameter and 5 µm in height. To construct a mold surface 
with this pattern, a 4-inch diameter silicon wafer is coated 
with a 5 µm thick layer of SU-8 2005 by spin coating at 3000 
rpm for about 30 seconds. The wafer is then placed on a 
hotplate at 65° C. for about 1 minute and then at 95° C. for 
about 2 minutes. The wafer is then exposed to UV light 
through a photomask defining the array of cylinders using, for 
example, a mask aligner (Karl Suss MA-6). The exposure 
time is calculated to give an exposure energy of75 mJ/cm2 at 
a wavelength of365 nm. The exposed areas of the photoresist 
are then crosslinked by heating the wager on a hotplate at 65° 
C. for about 1 minute and then at 95° C. for about 1 minute. 
The unexposed areas of the photoresist are then dissolved 
away by immersing the wafer in solvent (SU-8 Developer, 
MicroChem, Newton, Mass.) for about 1 minute with con-
tinuous gentle agitation. The completed wafer is then rinsed, 
for example, with isopropyl alcohol and dried in a stream of 
nitrogen. Profilometry measurements and evaluation by scan-
ning electron microscopy can be used to verify that the 
desired surface pattern is produced. 
Example 2 
A more complicated pattern for a hydrogel mold surface, in 
accordance with the present invention when generated could 
for example, consist of an array of cylinders 100 µmin diam-
eter and 100 µmin height. Each cylinder is topped with a 
smaller array of cylinders, 5 µmin diameter, and 5 µmin 
height. The construction of such a mold requires two layers of 
photoresist and two separate exposures of those layers. First, 
a 4-inch diameter silicon wafer is coated with a 100 µm thick 
layer of SU-8 2050 by spin coating at 1700 rpm for about 30 
seconds. The wafer is then placed on a hotplate at 65° C. for 
about 4 minutes and then at 95° C. for about 1 minute. The 
wafer is then exposed to UV light through the photomask 
defining the array of large cylinders, using, for example, a 
mask aligner (Karl Suss MA-6). The exposure time is calcu-
lated to give an exposure energy of 450 mJ/cm2 at a wave-
length of365 nm. 
The exposed areas of the photoresist are then cross-linked 
by heating the waferon a hotplate at 65° C. for about 1 minute 
and then at 95° C. for about 9 minutes. Without developing the 
first layer, the wafer was coated with a 5 µm thick layer of 
SU-8 2005 by spin coating at 3000 rpm for about 30 seconds. 
The wafer is then placed on a hotplate at 65° C. for about 1 
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minute and then at 95° C. for about 2 minutes. The wafer is 
then exposed to UV light through the photomask defining the 
array of small cylinders using, for example, a mask aligner 
(Karl Suss, MA-6). The exposure time is calculated to give an 
exposure energy of7 5 mJ/cm2 at a wavelength of365 nm. The 
exposed areas of the photoresist are then crosslinked by heat-
ing the wafer on a hotplate at 65° C. for about 1 minute and 
thenat 95° C. for about 1 minute. Finally, the unexposed areas 
ofboth photoresist layers are then dissolved away by immers-
ing the wafer in solvent (SU-8 Developer, MicroChem, New- 10 
ton, Mass.) for about 9 minutes with continuous gentle agi-
tation. The completed wafer is then rinsed with, for example, 
isopropyl alcohol and dried in a stream of nitrogen. Profilo-
metry measurements and evaluation by scanning electron 15 
microscopy can be used to verify that the desired surface 
pattern has been produced. 
Example 3 
14 
strate could have been generated with this pattern out of any 
of the materials described herein. 
Example 4 
Solid polystyrene objects having complex shapes may be 
fabricated from uniform polystyrene beads by chemically 
attaching beads of different sizes. This is illustrated by the 
following example. 
To a suspension of carboxyl-modified polystyrene beads 
(20.3 µm+/-0.43 µmdiameter, Bangs Laboratories) in 20 mM 
MES, pH 4.5 is added a 10-fold excess of water-soluble 
carbodiimide, 1-Ethy 1-3-(3-dimethy laminopropy l)carbodi-
imide hydrochloride. After 15 minutes at room temperature, 
the beads are washed twice by centrifugation and suspension 
in 20 mM HEPES, pH 7.5 and then resuspended in the same 
buffer. This suspension is added to a stirred suspension of a 
sufficient amount ofamino-modified polystyrene beads (3.10 
Under the methods of this invention, enhanced differentia-
tion of cells into bone or bone-like cells is seen. Specifically, 
experiments were run using the PVA-H of this invention in 
multiple forms. This description references FIGS. 3-5 for 
clarity. As shown in FIG. 3 there were seven conformations of 
the surface topography taught by this invention used in this 
experiment--one being smooth hydrogel. Specifically, con-
formation is described using a two number nomenclature 
system such as PVA-H 10/2. PVA-H 10/2 refers first to the 
size of the large pore on the surface. As described above, the 
large pore can exist in a complex structure resembling a 
snowflake. The number 10 in the first position represents a 
large pore of 100 µm in diameter. The number in the second 
position of the nomenclature system refers to the size and 
20 µm+/-0.06 µm diameter, Bangs Laboratories) to give a 
25-fold molar excess of amino groups over carboxyl groups, 
in the same buffer. After 3 hours at room temperature, the 
unreacted excess smaller beads are removed. Microscopic 
examination shows substantially monodisperse particles 
25 composed of20-µm beads having the majority of their surface 
covered with a single layer of 3-µm beads. 
The polystyrene objects of the foregoing example may be 
used as a template to fabricate a mold for providing the 
desired porous surface of the hydrogels of the present inven-
30 ti on. This may be accomplished by making a metallic replica 
of a surface comprising a plurality of polystyrene objects 
using sputtering and/or metal plating techniques and the like, 
all of which are well known to those skilled in the art. The 
metallic replica thus produced may be replicated again and 
35 
arrangement of the small pores superimposed on the large 
pore surface. The second position numbers of 2, 5, and 10 
refer to a diameter of 2 µm, 5 µm, and 10 µm, respectively. The 
spacing and orientation of the small pores on the large pore 
surface follows a hexagonal grid with a spacing between the 40 
small pores of twice the diameter of the small pores. 
Moving clockwise through FIG. 3, surfaces are shown 
possessing a 100 µm large pore with a 2 µm small pore (10/2) 
50, a 100 µm large pore with a 5 µm small pore (10/5) 55, a 
100 µm large pore with a 10 µm small pore (10/10) 60, no 45 
large pore with 10 µm small pores (0/10) 65, no large pore 
with 5 µm small pores (0/5) 70, and no large pore with 2 µm 
small pores (0/2) 75. Not shown is smooth PVA-H which 
would receive the 0/0 designation in the above described 
nomenclature. 50 
FIGS. 4 and 5 when taken together indicate that while 
tissue culture plastic provides for the greatest amount of 
cellular proliferation, textured PVA-Hs promote increased 
differentiation into bone or bone-like cells. MG63 cells were 
cultured in conditioned media on the surfaces. Specifically, 55 
the cells cultured on the 10/10 conformation 60 showed the 
greatest level of secreted osteocalcin. The next highest 
amount of osteocalcin secretion was seen in the 10/5 confor-
mation 55. This indicates the enhanced ability to generate 60 
differentiation into bone or bone-like cells by the mimicking 
of native osteoclastic resorption sites on PVA-H by the use of 
the present invention. 
FIG. 6 is an image of the surface of a substrate manufac-
tured in accordance with the present invention. The image 65 
shows the surface of a hydrogel that was cast in a mold similar 
to those depicted in FIG. 3. It should be noted that the sub-
reinforced with further metal or other components, again 
using methods well known to those skilled in the art. The 
result is a mold suitable for producing the complex surface 
texture of the hydrogels of the present invention. 
Although the invention has been described with reference 
to a particular preferred embodiment with its constituent 
parts, features and the like, these are not intended to exhaust 
all possible arrangements, mechanical and electrical equiva-
lents, or features, and indeed many other modifications and 
variations will be ascertainable to those of skill in the art. 
What is claimed is: 
1. An implant configured for insertion into a patient's joint, 
said implant comprising: 
a first surface and a depth extending from the first surface 
to a second surface generally opposite the first surface; 
a plurality of first cavities along the first surface of the 
implant, each of said first cavities extending to a bottom 
surface of said first cavity; 
wherein the first cavities are larger than the second cavities; 
and 
a plurality of second cavities located below at least one of 
the first cavities, each of said second cavities extending 
from the bottom surface of at least one of the first cavi-
ties; 
wherein said first cavities are only located on the first 
surface of the implant and do not extend throughout the 
depth of said implant; and 
wherein the second cavities do not extend throughout the 
depth of the implant. 
2. The implant of claim 1, wherein the implant is a load 
bearing device that is configured for implantation in a knee, 
shoulder or spine. 
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3. The implant of claim 1, wherein the first cavities pro-
mote differentiation of a first cell type, and wherein the sec-
ond cavities promote differentiation of a second cell type. 
4. The implant of claim 1, wherein at least some of the first 
cavities promote attraction of bone cells. 
5. The implant of claim 1, wherein at least some of the 
second cavities promote anchoring and growth of bone cells. 
6. The implant of claim 1, wherein the implant comprises 
bone and cartilage forming cells or precursor cells to bone and 
cartilage forming cells. 
7. The implant of claim 1, wherein the implant comprises 
one or more of the following cells types: osteoblasts, chon-
drocytes, mesenchymal stem cells and osteoprogenitor cells. 
8. The implant of claim 1, wherein said implant comprises 
10 
at least one bioactive factor to stimulate growth or differen- 15 
tiation of cells. 
9. The implant of claim 1, wherein the first cavities and the 
second cavities are within 1 millimeter of the first surface of 
the implant. 
10. The implant of claim 1, wherein the first cavities and the 20 
second cavities are within 200 micrometers of the first surface 
of the implant. 
11. The implant of claim 1, wherein the implant comprises 
a moisture content of at least 5% w/w of the overall of the 
implant. 25 
12. The implant of claim 1, wherein the implant comprises 
a moisture content of at least 30% w/w of the overall of the 
implant. 
13. The implant of claim 1, wherein the first cavities have 
an average cross-section of between 10 to 300 micrometers. 30 
14. The implant of claim 1, wherein the first cavities have 
an average cross-section of between 30 and 100 micrometers. 
16 
15. The implant of claim 1, wherein the second cavities 
have an average cross-section of between 1 to 10 microme-
ters. 
16. The implant of claim 1, wherein the second cavities 
have an average cross-section of between 2 to 5 micrometers. 
17. The implant of claim 1, wherein the implant comprises 
a hydrogel. 
18. A biocompatible substrate having an outer surface and 
a depth, the biocompatible substrate comprising: 
a plurality of first cavities along the outer surface of the 
biocompatible substrate, each of said first cavities 
extending to a bottom surface of said first cavity; and 
a plurality of second cavities located below at least one of 
the first cavities, each of said second cavities extending 
from the bottom surface of the first cavity; 
wherein the first cavities are larger than the second cavities; 
wherein said first cavities are only located along the outer 
surface of the biocompatible substrate and do not extend 
throughout the depth of said biocompatible substrate; 
wherein said second cavities do not extend throughout the 
depth of the biocompatible substrate; and 
wherein the biocompatible substrate is a load bearing 
device that is configured for implantation in a joint. 
19. The biocompatible substrate of claim 18, wherein the 
first cavities and the second cavities are within 1 millimeter of 
the outer surface of the biocompatible substrate. 
20. The biocompatible substrate of claim 18, wherein the 
first cavities have an average cross-section of between 10 to 
300 micrometers. 
* * * * * 
